CSO in Lytix Biopharma, Øystein Rekdal, is invited to give a presentation at the 37th Scandinavian Sarcoma group (SSG) meeting in Stockholm 20th of May 2015.
The SSG was formed in 1979 by physicians and scientists from the Scandinavian countries with a primary interest in tumors of connective tissues.
The goal of the SSG is to advance the care of patients with sarcoma and to increase knowledge of all aspects of the biology of these tumors, including basic and clinical research. The SSG has developed treatment protocols for different sarcoma types and participates in international clinical trials.
CSO Øystein Rekdal